[促甲状腺激素结合抑制性免疫球蛋白（TBII）检测在格雷夫斯病患者中的临床应用：抗甲状腺药物治疗对TBII及预后的影响] - Suppr | 超能文献

[Clinical usefulness of the assay of TSH-binding inhibitor immunoglobulins (TBII) in patients with Graves' disease: Effect of antithyroid drug treatment on TBII and prognosis].

作者信息

Iida Y, Konishi J, Kousaka T, Misaki T, Nakajima T, Endo K, Torizuka K

出版信息

Kaku Igaku. 1983 Dec;20(10):1425-31.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

[Clinical usefulness of the assay of TSH-binding inhibitor immunoglobulins (TBII) in patients with Graves' disease: Effect of antithyroid drug treatment on TBII and prognosis].[促甲状腺激素结合抑制性免疫球蛋白（TBII）检测在格雷夫斯病患者中的临床应用：抗甲状腺药物治疗对TBII及预后的影响]

Kaku Igaku. 1983 Dec;20(10):1425-31.

2

[The prognosis of Graves' disease after antithyroid drug treatment: clinical significance of the T3 suppression test and abnormal thyroid stimulators].

Nihon Naibunpi Gakkai Zasshi. 1982 Jun 20;58(6):796-806. doi: 10.1507/endocrine1927.58.6_796.

3

Concentration of TSH-receptor antibodies (TBII) in the sera of patients with immunogenic hyperthyroidism (Graves' disease) receiving antithyroid medication.接受抗甲状腺药物治疗的免疫性甲状腺功能亢进症（格雷夫斯病）患者血清中促甲状腺激素受体抗体（TBII）的浓度。

Radiobiol Radiother (Berl). 1987;28(1):101-6.

4

Continued suppression of serum TSH level may be attributed to TSH receptor antibody activity as well as the severity of thyrotoxicosis and the time to recovery of thyroid hormone in treated euthyroid Graves' patients.血清促甲状腺激素（TSH）水平持续受到抑制，可能归因于促甲状腺激素受体抗体活性、甲状腺毒症的严重程度以及接受治疗的甲状腺功能正常的格雷夫斯病患者甲状腺激素恢复所需的时间。

Thyroid. 2006 Dec;16(12):1251-7. doi: 10.1089/thy.2006.16.1251.

5

[Clinical value of the determination of TSH-binding inhibitory immunoglobulins (TBII) by a radioreceptor assay].

Dtsch Z Verdau Stoffwechselkr. 1986;46(5):301-6.

6

Paired determination of thyroid-stimulating and TSH-binding inhibitory activities in patients with Graves' disease during antithyroid drug treatment.在接受抗甲状腺药物治疗的格雷夫斯病患者中对促甲状腺素和促甲状腺素结合抑制活性进行配对测定。

Acta Endocrinol (Copenh). 1986 Apr;111(4):474-80. doi: 10.1530/acta.0.1110474.

7

Remission of Graves' hyperthyroidism predicted by smooth decreases of thyroid-stimulating antibody and thyrotropin-binding inhibitor immunoglobulin during antithyroid drug treatment.抗甲状腺药物治疗期间，促甲状腺素抗体和促甲状腺素结合抑制免疫球蛋白水平平稳下降可预测格雷夫斯甲亢的缓解。

Thyroid. 2000 Oct;10(10):891-6. doi: 10.1089/thy.2000.10.891.

8

Detection of low titre TBII in patients with Graves' disease using recombinant human TSH receptor.使用重组人促甲状腺激素受体检测格雷夫斯病患者中的低滴度促甲状腺素受体抗体

Clin Endocrinol (Oxf). 2002 Aug;57(2):193-8. doi: 10.1046/j.1365-2265.2002.01577.x.

9

[Clinical studies on abnormal thyroid stimulators in patients with Graves' disease. II. Clinical significance of measuring TSAb and TBII in patients with euthyroid Graves' disease and patients with hyperthyroid Graves' disease during antithyroid drug treatment].[格雷夫斯病患者甲状腺刺激异常物的临床研究。II. 甲状腺功能正常的格雷夫斯病患者及抗甲状腺药物治疗期间甲状腺功能亢进的格雷夫斯病患者TSAb和TBII测定的临床意义]

Nihon Naibunpi Gakkai Zasshi. 1988 Mar 20;64(3):206-15. doi: 10.1507/endocrine1927.64.3_206.

10

Evaluation of TSH-receptor antibodies as prognostic markers after cessation of antithyroid drug treatment in patients with Graves' disease.

Acta Endocrinol (Copenh). 1988 Feb;117(2):173-80. doi: 10.1530/acta.0.1170173.

引用本文的文献

1

Thyrotropin binding inhibiting antibody (TBIAb) in Graves' disease.

Korean J Intern Med. 1988 Jan;3(1):45-51. doi: 10.3904/kjim.1988.3.1.45.

2

Clinical course and thyroid stimulating hormone (TSH) receptor antibodies during surgical treatment of Graves' disease.格雷夫斯病手术治疗期间的临床病程及促甲状腺激素（TSH）受体抗体

World J Surg. 1992 Jul-Aug;16(4):647-52; discussion 652-3. doi: 10.1007/BF02067345.